TL;DR
A 2026 paper in The Lancet Healthy Longevity argues that sarcopenia should be understood as decline across the motor system, including the brain, spinal cord, nerves and muscles. The authors say practical tests and treatments need validation before this proposed framework can replace or improve current approaches.
A paper in The Lancet Healthy Longevity argues that weakness and mobility loss in older adults cannot be explained by muscle loss alone, proposing that sarcopenia be understood as decline across the whole motor system. The authors say the brain, spinal cord, nerves and their connections to muscles may all contribute, a view that could change how clinicians assess and research age-related loss of function.
Get oils, diffusers and self-care delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The paper, by Lucas B. R. Orssatto and co-authors, challenges the longstanding tendency to treat sarcopenia chiefly as a muscle disease. Sarcopenia is associated with loss of muscle, strength and physical function, and the Medical Xpress report says it affects up to 29% of older adults living in the community, with higher rates in hospitals, residential care and among people with multiple health conditions or frailty.
The authors point to a gap between diagnostic measures and explanations of the condition. Current approaches increasingly use grip strength, walking speed and chair stands, rather than muscle mass alone, because these measures predict outcomes such as falls and disability more effectively, the report says. Yet the underlying account often still treats weakness as a direct result of muscle wasting. The authors argue that muscle loss explains only a modest share of the strength decline seen with age, and that people with similar muscle amounts can have different levels of strength and mobility.
They propose that age-related changes in movement control may help explain that variation. Their motor-system account includes slower movement planning, less reliable or weaker nerve signals, and declines in balance and position sense. The paper sets out a five-point agenda for international groups that develop diagnostic criteria. It also suggests clinicians consider movement speed, balance, dexterity and walking while performing another task, alongside existing strength and gait measures. These are proposals, not validated replacements for current screening.
A Broader View of Mobility Loss
The argument matters because weakness can affect everyday tasks and independence, while falls can cause serious injury. In Australia, the Medical Xpress report cites 253,800 fall-related hospitalizations in 2024–25. It also reports that 6,722 Australians died following a fall in the preceding year and that fall injuries cost the health system an estimated $5.4 billion. These figures describe the Australian burden; they do not establish that the proposed motor-system approach would reduce falls.
If the framework is borne out, it could shift research and care away from treatments aimed mainly at adding muscle and toward approaches that assess and address movement, strength and function together. The authors say exercise can improve strength and mobility even when measurable muscle mass does not change. That observation supports testing broader approaches, but does not by itself establish which interventions work best for a particular patient.
For patients, the proposal highlights why a clinician may need to look beyond body size or muscle quantity when someone reports slowing down or becoming less steady. For health systems, it raises a practical question: whether additional assessments can identify useful, treatable causes of decline without adding tests that do not improve outcomes.
Products Worth Considering

BowFlex Results Series 552 SelectTech Adjustable Dumbbell

Bowflex SelectTech 840 Adjustable Kettlebell

Garmin Forerunner 570 GPS Running Smartwatch, 42 mm, Aluminum, Bone/Mango
As an affiliate, we earn on qualifying purchases.
From Muscle Mass to Function
Clinical definitions of sarcopenia have already moved toward measures of strength and physical performance, rather than relying only on muscle mass. The paper argues that the explanation has not kept pace with that change: research and practice still often center on muscle tissue even though function depends on signals and coordination across the motor system.
The proposal comes as Australian primary care is being encouraged to address poor muscle health. Earlier in 2026, the Australian Journal of General Practice published a proposed algorithm for screening, assessment and management in primary care, according to Medical Xpress. The new paper does not report a clinical trial of a revised diagnostic process; it presents an argument and a research agenda for reconsidering the condition.
The report also describes a contrast in existing evidence: drug and protein strategies that build muscle have not always produced comparable gains in what people can do, while exercise may improve strength and mobility without a measurable increase in muscle mass. The authors use this to question a muscle-only model, not to claim that muscle is irrelevant.
“We propose that sarcopenia is better understood as a disease of the aging motor system.”
— Lucas B. R. Orssatto and co-authors, in their paper in The Lancet Healthy Longevity
Tests and Benefits Still Unproven
The authors acknowledge that it has not yet been shown whether the suggested measures perform better than existing screening approaches, either for patient outcomes or costs. The report does not provide trial results showing that the motor-system framework prevents falls, preserves independence or improves treatment response.
It is also unclear which proposed tests would be practical and reliable in routine primary care. Neuromuscular expertise is not evenly available, and the paper calls for validation of usable tests, staged guidelines and trials that assess nerves as well as muscle. Until that evidence exists, the proposal should be treated as a research direction rather than a replacement for established care.
Validation Before Practice Changes
The authors call for international working groups responsible for diagnostic criteria to consider their five-point agenda. They also want researchers to validate practical assessments, develop guidance for staged evaluation and run trials measuring both nerve and muscle function. No timeline for those steps is specified in the source material.
For now, the paper adds a framework for studying age-related weakness, while leaving existing screening and management approaches in place. Whether broader motor-system assessments lead to better decisions or outcomes will depend on future evidence.
Key Questions
What is sarcopenia?
Sarcopenia is a condition involving loss of muscle, strength and physical function associated with aging. The paper argues that its causes may extend beyond muscle tissue.
What does the motor-system explanation include?
It includes the brain, spinal cord, nerves and their connections to muscle, along with changes in movement planning, signal transmission, balance and position sense.
Does the paper prove that a new assessment prevents falls?
No. The authors say it remains unproven whether their suggested measures outperform existing screens on outcomes or cost. The paper proposes further testing.
What tests do the authors suggest studying?
Alongside strength and gait speed, they suggest examining how quickly a person rises from a chair, steadiness during sustained effort, hand dexterity and walking while carrying on a conversation. These suggestions require validation before their value is established.
Source: medicalxpress.com
